Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q4 2023 Results Conference Call August 31, 2023 8:30 AM ET Company Participants Jeff Sonnek - IR-ICR Jim Hall - President, CEO John Morberg - CFO Operator Good morning, and thank you for joining Lifecore's Fiscal 2023 Fourth Quarter Earnings Call. [Operator Instructions]. Now I'd like to turn the call over to Jeff Sonnek, Investor Relations at ICR. Jeff Sonnek Good morning, and thank you for joining us today to discuss Lifecore Biomedical's Fourth Quarter and Full Yea ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Quarter Ended February 26, 2023, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition period for _________ to _________. Commission file number: 000-27446 LIFECORE BIOMEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 94 ...

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2023 Earnings Conference Call June 1, 2023 8:30 AM ET Company Participants Jim Hall - President John Morberg - CFO Conference Call Participants Operator Good morning, and thank you for joining us today to discuss Lifecore Biomedical's Third Quarter Fiscal 2023 Earnings Results. Hosting the call today from the company are Jim Hall, President and Chief Executive Officer; and John Morberg, Chief Financial Officer. Before we begin today, I'd like to remind everyone of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Quarter Ended November 27, 2022, or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition period for _________ to _________. Commission file number: 000-27446 LIFECORE BIOMEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 94 ...

Landec Corporation (LNDC) Q1 2023 Earnings Conference Call October 6, 2022 8:00 AM ET Company Participants Jeff Sonnek - Investor Relations, ICR Jim Hall - Chief Executive Officer John Morberg - Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Mark Smith - Lake Street Capital Markets Mike Petusky - Barrington Research Mitch Pinheiro - Sturdivant & Company Operator Good morning and thank you for joining Landec's Fiscal 2023 First Quarter Earnings Call. During the presentation, al ...

Landec Corporation (LNDC) Q4 2022 Earnings Conference Call August 10, 2022 5:00 PM ET Company Participants Jeff Sonnek - Investor Relations, ICR Jim Hall - Chief Executive Officer John Morberg - Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Mike Petusky - Barrington Research Connor Jensen - Lake Street Capital Markets Operator Good afternoon and thank you for joining Landec's Fiscal 2022 Fourth Quarter Earnings Call. During the presentation, all participants will be in a list ...

www.lifecore.com CONFIDENTIAL 1 (Nasdaq: LNDC) Lifecore Biomedical Investor Presentation April 2022 Progress made possible Important Information Regarding Forward-Looking Statements This presentation contains forward-looking statements regarding future events and our future results that are subject to the safe harbor created under the Private Securities Litigation Reform Act of 1995 and other safe harbors under the Securities Act of 1933 and the Securities Exchange Act of 1934. Words such as "anticipate", " ...

Landec Corporation (LNDC) Q3 2022 Earnings Conference Call March 5, 2022 5:00 PM ET Company Participants Jeff Sonnek - IR, ICR, Inc. Albert Bolles - President and Chief Executive Officer John Morberg - Chief Financial Officer Jim Hall - President, Lifecore Conference Call Participants Mark Smith - Lake Street Capital Markets Mitch Pinheiro - Sturdivant & Co Michael Petusky - Barrington Research Operator Good afternoon and thank you for joining Landec's Fiscal 2022 Third Quarter Earnings Call. [Operator Ins ...

www.lifecore.com CONFIDENTIAL 1 (Nasdaq: LNDC) Lifecore Biomedical Investor Presentation January 2022 Progress made possible Important Information Regarding Forward-Looking Statements This presentation contains forward-looking statements regarding future events and our future results that are subject to the safe harbor created under the Private Securities Litigation Reform Act of 1995 and other safe harbors under the Securities Act of 1933 and the Securities Exchange Act of 1934. Words such as "anticipate", ...

Landec Corporation (LNDC) Q2 2022 Earnings Conference Call January 5, 2022 5:00 PM ET Company Participants Jeff Sonnek - Managing Director, ICR Albert Bolles - President and Chief Executive Officer Jim Hall - President-Lifecore John Morberg - Chief Financial Officer Conference Call Participants Gerry Sweeney - ROTH Capital Partners Mark Smith - Lake Street Capital Markets Mitchell Pinheiro - Sturdivant & Co Anthony Vendetti - Maxim Group Operator Good afternoon, and thank you for joining Landec's Fiscal 2 ...